Sayson, Karen, NONE. R.
HRN: 22-07-11 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/30/2022
METRONIDAZOLE 500MG (TAB)
10/30/2022
11/06/2022
ORAL
500mg
TID
H.pylori Infection
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes